CURR
Currenc Group Inc.
stockNASDAQ
cure pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. cure has an industry leading full-service cgmp manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system (curefilm™), the most advanced oral thin film on the market today. cure has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. cure has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the u.s., canada, israel and germany, among other markets. our mission is to improve people's lives by redefining how medicines are delivered and experienced.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.11 | 2026-09-28 | +0.16% | -0.912 |
| 1M | 3.29 | 2026-09-04 | -5.32% | -1.653 |
| 3M | 2.75 | 2026-07-06 | +13.27% | -1.105 |
| 6M | 2.89 | 2026-04-06 | +7.79% | 0.863 |
| 1Y | 1.57 | 2025-10-03 | +98.41% | 1.066 |
| 2Y | 2.31 | 2024-10-04 | +34.85% | — |
| 5Y | 0.68 | 2021-10-04 | +358.43% | -1.478 |
Currenc Group Inc. (NASDAQ:CURR) stock price today is $3.12, and today's volume is 84,583. CURR is down 1.111% today. The 30 day average volume is 504,509. CURR market cap is $349.76M with 112.28M shares outstanding.